We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Fastnet Equity | LSE:FAST | London | Ordinary Share | GB00B85HRF56 | ORD 3.8P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.975 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
22/1/2016 10:50 | Pollack have you any idea whatsoever what discussions are taking place? No of course, you haven't the faintest idea. It's probably a safe bet to say that you are not a businessman. The best deals take time. There have been discussions taking place, and there will be more. Do you think Friel just turns up to his office and puts on Skysports news? Buffy | buffythebuffoon | |
22/1/2016 07:41 | In the news again today. Pharma companies asking government to help identify new ways to fund them. Cathal are you listening to them. AIM stands for alternative investment market, the clue is in the name ffs. AIM isn't just to pay directors salaries and other admin. Get of your backside after six months and do something with these pharma companies. | jacksonpollack | |
21/1/2016 21:24 | Bounced off the lower Bollinger Band today. free stock charts from uk.advfn.com | papillon | |
21/1/2016 20:31 | Boring zzzzzzzz | jacksonpollack | |
20/1/2016 22:40 | I increased my spreadbet today by another £500 per penny, this is now my only position in these uncertain markets. With the cash in the bank; this has to be the lowest risk position available. For every .1p we drop I will gladly keep adding. When will an announcement come? Personally I think it's imminent, I believe the directors aren't able to buy now for exactly that reason. A matter of days or a few weeks at most. IMO Karl | karlm | |
20/1/2016 22:11 | FAST is a excellent gamble at this price. | papillon | |
20/1/2016 20:25 | The thing you need to consider when deciding when to buy is that probably when any deal is announced the shares will be suspended The share price when the shares are readmitted will depend very much on the quality of the rto and the way the deal is structured all of which are currently unknown which is the reason you can currently buy bucket loads in the 2-3p range What we do know is CF bought out major shareholders at 4p presumably for a reason Harry Stratford is no mug in this sector as demonstrated by his cv The shares are trading sub cash value A deal is likely before August otherwise the shares will be suspended and surplus cash returned to shareholders At the moment there is some margin of safety in terms of cash and time to complete the deal Basicaly it is a gamble but in 2-3p region may pay off in spectacular fashion if Shire is anything to go by Good luck whatever you decide | risk1 | |
20/1/2016 20:19 | I'm assuming any announcements will be regarding an investment in a bio company. We will then have to wait to see how that performs before any real movement here? Thinking of when to buy. | qalbabbass | |
20/1/2016 20:12 | Maybe 2p maybe not who knows The question is when will the announcement come as when it does even 3p may sound very cheap Fingers crossed | risk1 | |
20/1/2016 19:31 | Back to 2p yet again? Definitely not boring. Like being on a rollercoaster!! | papillon | |
20/1/2016 17:54 | Boring zzzzzzz | jacksonpollack | |
20/1/2016 13:41 | Yep that looks more likely papillon, with the timings of the trades. | sea7 | |
19/1/2016 22:58 | If they get these details sorted it gives them credibility in my opinion. Is news getting closer I wonder? | risk1 | |
19/1/2016 22:54 | Looks like my call has done the trick website updated well done FAST!!!!!!! | risk1 | |
19/1/2016 19:33 | They were probably a rollover, sea7, done at, or near, the then asking price since they were only 25 seconds apart. 250k sold at 2.73p and then bought back 25 seconds later at 2.75p. That's probably why the FAST share price didn't move which it probably would have done on 2 x 250k buys. | papillon | |
19/1/2016 19:04 | Yep risk1, looks as though someone waited until it went below the current cash value and added twice. | sea7 | |
19/1/2016 18:50 | Those 2 x 250k lots were against the run of play in recent days? | risk1 | |
19/1/2016 18:46 | Pap, I seem to recall that it is fairly standard practice to call up larger holders that you know of and try to buy their stake, or a part of it, off market and then announce it, if required. Cathal bought 3,555,394 shares on the 3/7/2015 and 17,308,080 on the 27th June 2015. Two purchases, totalling 20,863,474 shares done in two transactions 6 days apart. Can you imagine how quick the share price would have gone up and by how much, if cathal had simply dumped a buy order for over 20m shares onto fastnets relatively illiquid market. Todays volume was 677k shares, which was more than Fridays volume of around 400k shares | sea7 | |
19/1/2016 18:38 | Yep pap true, aim is leaky, although the company is expected to disclose any rto news immediately, if they feel that it has leaked out. In accordance with the aim rules. | sea7 | |
19/1/2016 18:11 | "The stock is trading at less than the cash value at end November 2016 and may drift further without news." Or rise before news if that news leaks, sea. Leaks are not unheard of with AIM shares! LOL. | papillon | |
19/1/2016 18:09 | "Buying theirs in one transaction each, meant not having to go into the market and see the price spike above 4p on news of him buying, making it more expensive for him to acquire the stake he wanted." That's a logical and rational reason, sea7, probably too logical and rational for Jackson to grasp. | papillon | |
19/1/2016 17:09 | Well, aim rules state that they expect negotiations surrounding a RTO to take place confidentially and the announcement of a deal or contemplation of a deal is to be made public and the shares suspended at the same time. So, if they have been in meetings with potential RTO targets, then we probably won't know until the day of suspension. Cathal did state in the investing policy that cash would be used to investigate potential targets, however, no guarantee of any susbsequent acquisition taking place. With EUR13m in the kitty, after the fastnet hydrocarbon loan, they ought not to spend to much investigating. The stock is trading at less than the cash value at end November 2016 and may drift further without news. | sea7 | |
19/1/2016 16:43 | Just rang fastnet and queried the missing info, somebody is going to phone me back,they have been in meetings all day,make of that what you will | risk1 | |
19/1/2016 16:24 | Aim rule 26 compliance states that the website should contain the names of the directors and a brief biography of each of them. Whilst Harry does not show up on the actual directors page, it is shown in the news release dated 21 December 2015 and available on the home page. So, it would therefore appear to be just about compliant. Cathals reasons for buying out former holders at 4p can be many, however, simply acquiring their shares at a premium to prevent them from trying to block a move to the life sciences sector is one. Buying theirs in one transaction each, meant not having to go into the market and see the price spike above 4p on news of him buying, making it more expensive for him to acquire the stake he wanted. As for companies house... He is there as STRATFORD, Harry Thomas - the filing of the appointment of him was done today, according to companies house | sea7 | |
19/1/2016 13:18 | interesting article from the FT : Orphan drugs become big business | soul limbo |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions